Evidence map›Paper›PMID 40473777›Full record

ReviewEuropean journal of human genetics : EJHG2025

RNA-based diagnostic studies in genetics: Review and guidance from a multidisciplinary French network.

Marie-Pierre Buisine, Christine Bellanne-Chantelot, Nadège Calmels, Christel Vaché, Thomas Besnard, Benjamin Cogne, Antonio Vitobello, Amélie Piton, Alexandra Martins, Pascaline Gaildrat and 8 more

Abstract readReview
In one paragraph

Review in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Journal of human immunity · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Insights in genetics: from molecular mechanisms to patient perspectives.European journal of human genetics : EJHG · 2025
    Article
  7. Uncertainty, ethics, and progress in genomic medicine.European journal of human genetics : EJHG · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Marie-Pierre BuisineUniv. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000, Lille, France.
Christine Bellanne-ChantelotAP-HP. Sorbonne University, Pitié-Salpêtrière Hospital, Department of Medical Genetics, F-75013, Paris, France.ORCID 0000-0001-8415-6771
Nadège CalmelsLaboratoire de Diagnostic Génétique, Institut de Génétique Médicale D'Alsace, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg, France.
Christel VachéLaboratoire de génétique moléculaire, Univ Montpellier, CHU Montpellier, Montpellier, France.ORCID 0000-0001-7076-9139
Thomas BesnardService de Génétique médicale, Nantes Université, CHU de Nantes, Nantes, France.
Benjamin CogneService de Génétique médicale, Nantes Université, CHU de Nantes, Nantes, France.ORCID 0000-0002-5503-6292
Antonio VitobelloUniversité Bourgogne Europe, CHU Dijon Bourgogne, service de Génomique Médicale, Centre de recherche Translationnelle en Médecine moléculaire (CTM) - Inserm UMR1231 équipe Génétique des Anomalies du Développement (GAD), 21000, Dijon, France.ORCID 0000-0003-3717-8374
Amélie PitonInstitute for Genetics and Molecular and Cellular Biology (IGBMC), University of Strasbourg, CNRS UMR7104, INSERM U1258, Illkirch, France.ORCID 0000-0003-0408-7468
Alexandra MartinsUniv Rouen Normandie, Inserm U1245, Normandie Univ, FHU-G4 génomique, F-76000, Rouen, France.ORCID 0000-0003-4322-8497
Pascaline GaildratUniv Rouen Normandie, Inserm U1245, Normandie Univ, FHU-G4 génomique, F-76000, Rouen, France.
Claire-Marie DhaenensUniv. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.
Svetlana GorokhovaMedical Genetics Department, Timone Children's Hospital, APHM, 13385, Marseille, France.ORCID 0000-0001-6870-4061
Nadia Boutry-KryzaDepartment of Genetics, Groupement Hospitalier EST, Hospices Civils de Lyon, 69500, Bron, France.
Sandrine CaputoDepartment of Genetics, Institut Curie, Paris, France.ORCID 0000-0001-5338-9388
Raphaël LemanLaboratoire de Biologie et Génétique des Cancers, Centre François Baclesse, FHU-G4 génomique, 14000, Caen, France.
Sophie KriegerLaboratoire de Biologie et Génétique des Cancers, Centre François Baclesse, FHU-G4 génomique, 14000, Caen, France.
Gérald Le GacUniv Brest, Inserm, EFS, UMR 1078, CHU de Brest, Service de Génétique Médicale et Biologie de la Reproduction, F-29200, Brest, France.
Claude HoudayerUniv Rouen Normandie, Inserm U1245, Normandie Univ, FHU-G4 génomique, CHU Rouen, Département de Génétique, F-76000, Rouen, France. claude.houdayer@chu-rouen.fr.ORCID 0000-0002-5190-0389

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread use of high-throughput sequencing for genetic diagnosis has led to considerable advances in patient care, but interpretation of the variants identified remains a challenge and geneticists routinely face the question of variants of uncertain significance. The clinical interpretation of genomic variants requires a high level of expertise to ensure appropriate genetic counseling. Assessing the impact of variants on splicing is a key issue in order to determine their pathogenicity as each variant can impact pre-mRNA splicing by disruption of the splicing code. It is for this reason that a diverse group of French molecular and clinical genetics experts from different diagnostic laboratories nationwide was established to discuss splicing issues and elaborate diagnostic recommendations. We describe an update of these recommendations with the aim of highlighting the importance of transcript characterization for variant interpretation and facilitating the diagnostic implementation of transcript studies, an important source of new diagnostics in human genetics.

Indexed as

Genetic TestingPractice Guidelines as TopicFranceHigh-Throughput Nucleotide SequencingHumansRNA Splicing

Identifiers

PMID40473777
PMCPMC12480862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.